119 related articles for article (PubMed ID: 33846140)
1. A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer.
Kloesch B; Ionasz V; Paliwal S; Hruschka N; Martinez de Villarreal J; Öllinger R; Mueller S; Dienes HP; Schindl M; Gruber ES; Stift J; Herndler-Brandstetter D; Lomberk GA; Seidler B; Saur D; Rad R; Urrutia RA; Real FX; Martinelli P
Gut; 2022 Apr; 71(4):766-777. PubMed ID: 33846140
[TBL] [Abstract][Full Text] [Related]
2. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.
Martinelli P; Carrillo-de Santa Pau E; Cox T; Sainz B; Dusetti N; Greenhalf W; Rinaldi L; Costello E; Ghaneh P; Malats N; Büchler M; Pajic M; Biankin AV; Iovanna J; Neoptolemos J; Real FX
Gut; 2017 Sep; 66(9):1665-1676. PubMed ID: 27325420
[TBL] [Abstract][Full Text] [Related]
3. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
de Andrés MP; Jackson RJ; Felipe I; Zagorac S; Pilarsky C; Schlitter AM; Martinez de Villareal J; Jang GH; Costello E; Gallinger S; Ghaneh P; Greenhalf W; Knösel T; Palmer DH; Ruemmele P; Weichert W; Buechler M; Hackert T; Neoptolemos JP; Notta F; Malats N; Martinelli P; Real FX
Gut; 2023 Mar; 72(3):535-548. PubMed ID: 36109153
[TBL] [Abstract][Full Text] [Related]
4. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery.
van Eijck CWF; Real FX; Malats N; Vadgama D; van den Bosch TPP; Doukas M; van Eijck CHJ; Mustafa DAM;
Cell Rep Med; 2024 May; 5(5):101557. PubMed ID: 38733987
[TBL] [Abstract][Full Text] [Related]
5. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Brunton H; Caligiuri G; Cunningham R; Upstill-Goddard R; Bailey UM; Garner IM; Nourse C; Dreyer S; Jones M; Moran-Jones K; Wright DW; Paulus-Hock V; Nixon C; Thomson G; Jamieson NB; McGregor GA; Evers L; McKay CJ; Gulati A; Brough R; Bajrami I; Pettitt SJ; Dziubinski ML; Barry ST; Grützmann R; Brown R; Curry E; ; ; Pajic M; Musgrove EA; Petersen GM; Shanks E; Ashworth A; Crawford HC; Simeone DM; Froeling FEM; Lord CJ; Mukhopadhyay D; Pilarsky C; Grimmond SE; Morton JP; Sansom OJ; Chang DK; Bailey PJ; Biankin AV
Cell Rep; 2020 May; 31(6):107625. PubMed ID: 32402285
[TBL] [Abstract][Full Text] [Related]
6. Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.
Wang X; Kutschat AP; Aggrey-Fynn J; Hamdan FH; Graham RP; Wixom AQ; Souto Y; Ladigan-Badura S; Yonkus JA; Abdelrahman AM; Alva-Ruiz R; Gaedcke J; Ströbel P; Kosinsky RL; Wegwitz F; Hermann P; Truty MJ; Siveke JT; Hahn SA; Hessmann E; Johnsen SA; Najafova Z
Mol Cancer Res; 2023 Sep; 21(9):881-891. PubMed ID: 37279184
[TBL] [Abstract][Full Text] [Related]
7. Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease.
Martens S; Coolens K; Van Bulck M; Arsenijevic T; Casamitjana J; Fernandez Ruiz A; El Kaoutari A; Martinez de Villareal J; Madhloum H; Esni F; Heremans Y; Leuckx G; Heimberg H; Bouwens L; Jacquemin P; De Paep DL; In't Veld P; D'Haene N; Bouchart C; Dusetti N; Van Laethem JL; Waelput W; Lefesvre P; Real FX; Rovira M; Rooman I
Gut; 2021 Jul; 71(10):2030-42. PubMed ID: 34330784
[TBL] [Abstract][Full Text] [Related]
8. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.
Williams HL; Dias Costa A; Zhang J; Raghavan S; Winter PS; Kapner KS; Ginebaugh SP; Väyrynen SA; Väyrynen JP; Yuan C; Navia AW; Wang J; Yang A; Bosse TL; Kalekar RL; Lowder KE; Lau MC; Elganainy D; Morales-Oyarvide V; Rubinson DA; Singh H; Perez K; Cleary JM; Clancy TE; Wang J; Mancias JD; Brais LK; Hill ER; Kozak MM; Linehan DC; Dunne RF; Chang DT; Koong AC; Hezel AF; Hahn WC; Shalek AK; Aguirre AJ; Nowak JA; Wolpin BM
Cancer Res; 2023 Feb; 83(3):441-455. PubMed ID: 36459568
[TBL] [Abstract][Full Text] [Related]
9. High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer.
Michiels E; Madhloum H; Van Lint S; Messaoudi N; Kunda R; Martens S; Giron P; Olsen C; Lefesvre P; Dusetti N; El Mohajer L; Tomasini R; Hawinkels LJ; Ahsayni F; Nicolle R; Arsenijevic T; Bouchart C; Van Laethem JL; Rooman I
J Pathol; 2024 Jan; 262(1):76-89. PubMed ID: 37842959
[TBL] [Abstract][Full Text] [Related]
10. Association between
Greendyk JD; Allen WE; Alexander HR; Beninato T; Eskander MF; Grandhi MS; Kennedy TJ; Langan RC; Maggi JC; De S; Court CM; Ecker BL
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002058
[TBL] [Abstract][Full Text] [Related]
11. GATA6 inhibits the biological function of non-small cell lung cancer by modulating glucose metabolism.
Ju W; Lin L; Zhang Q; Lv X; Teng S; Hong Y; Shao Z; Na H; Yu S
J Cancer Res Clin Oncol; 2024 Mar; 150(3):126. PubMed ID: 38483616
[TBL] [Abstract][Full Text] [Related]
12. Monogenic Diabetes with GATA6 Mutations: Characterization of a Novel Family and a Comprehensive Analysis of the GATA6 Clinical and Genetics Traits.
Yue X; Luo Y; Wang J; Huang D
Mol Biotechnol; 2024 Mar; 66(3):467-474. PubMed ID: 37204622
[TBL] [Abstract][Full Text] [Related]
13. Marker-based CRISPR screening reveals a MED12-p63 interaction that activates basal identity in pancreatic ductal adenocarcinoma.
Maia-Silva D; Schier AC; Skopelitis D; Kechejian V; Alpsoy A; Liverpool J; Taatjes DJ; Vakoc CR
bioRxiv; 2023 Oct; ():. PubMed ID: 37961243
[TBL] [Abstract][Full Text] [Related]
14. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
15. Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells.
Breunig M; Merkle J; Wagner M; Melzer MK; Barth TFE; Engleitner T; Krumm J; Wiedenmann S; Cohrs CM; Perkhofer L; Jain G; Krüger J; Hermann PC; Schmid M; Madácsy T; Varga Á; Griger J; Azoitei N; Müller M; Wessely O; Robey PG; Heller S; Dantes Z; Reichert M; Günes C; Bolenz C; Kuhn F; Maléth J; Speier S; Liebau S; Sipos B; Kuster B; Seufferlein T; Rad R; Meier M; Hohwieler M; Kleger A
Cell Stem Cell; 2021 Jun; 28(6):1105-1124.e19. PubMed ID: 33915078
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.
Kaoutari AE; Fraunhoffer NA; Hoare O; Teyssedou C; Soubeyran P; Gayet O; Roques J; Lomberk G; Urrutia R; Dusetti N; Iovanna J
EBioMedicine; 2021 Apr; 66():103332. PubMed ID: 33862584
[TBL] [Abstract][Full Text] [Related]
17. Cell of Origin Influences Pancreatic Cancer Subtype.
Flowers BM; Xu H; Mulligan AS; Hanson KJ; Seoane JA; Vogel H; Curtis C; Wood LD; Attardi LD
Cancer Discov; 2021 Mar; 11(3):660-677. PubMed ID: 34009137
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing in pancreatic cancer.
Han J; DePinho RA; Maitra A
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):451-452. PubMed ID: 34040169
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
